chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood clot in her lung; lung problems; bronchial asthma; may have damaged her immune system; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient, self report)  A female consumer of unspecified age, reported that she received the second dose of BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection, Batch/Lot Number and Expiration date: UNKNOWN), via an unspecified route of administration on an unknown date as single dose for COVID-19 immunisation. Patient reported that after she received the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine, she developed lung problems. She also said she had blood clot in her lung, and had bronchial asthma. Patient wants to know if there have been many reports of this nature after vaccination. She said the vaccine may have damaged her immune system, and wants to know what Pfizer can do for her. She also said the vaccine was dangerous.  Information on the lot/batch number has been requested.
Approximately 2 minutes after inject, patient expressed "I do not feel good". Patient experienced flushness, and difficulty breathing. Patient self-administered 2 chewable children's Benadryl while RN drew up 0.3mL of epinephrine and administered in left thigh at 0757 time. EMS was notified. Vitals obtained at 0800 were BP 180/100, HR 133,  o2 100%. Vitals obtained at 0803 were BP 176/96, HR 94, o2 100%. EMS on scene by 0805. Patient transported via ambulance to emergency room  for observation. Patient was able to ambulate on her own with EMS at side.
Parent noted redness at injection site as day progressed.  On  8/24/19 in the office site was 2.5cm x 3.0 cm area of redness with mild induration.  Uses extremity fine
Red area around the injection in a circular shape about an inch. Tingling in the palm of the hand of the same arm as the vaccine. I took Benadryl 25mg in the evening for two days and the symptoms disappeared on the third or fourth day.
This spontaneous report as received from a 61 year old female consumer who refers to herself. The patient's pertinent medical history included: thyroid (NOS). The patient had drug reactions/allergies for animal serum. The patient's medical history included shingles in 1983. Concomitant therapies included ALEVE and unspecified thyroid medicine (dose, manufacturer not reported). On 10-NOV-2014 the patient was prescribed ZOSTAVAX (dose, strength not reported). The patient was administered a series of vaccines on the same day. The vaccines administered were ZOSTAVAX, as well as influenza virus vaccine (unspecified) (dose, strength not reported) and tetanus toxoid (dose, strength not reported) shots of unknown manufacturers. The patient stated that she developed pain within a week after receiving these vaccinations. The patient stated that she has pain across her back. The events were treated with NEOSPORIN and benzocaine (unspecified dose and manufacturer). The patient did not seek medical attention. No lab diagnostic performed. The outcome was reported as not recovered/not resolved. The relatedness between events and ZOSTAVAX was not reported. Additional information has been requested.
NO ADVERSE EVENTS FOR PATIENT.  MEDICAL ASSISTANT ACCIDENTALLY ADMINISTERED MONOVALENT PFIZER COVID 6 MONTHS - 4 YEARS DOSE INSTEAD OF BIVALENT PFIZER DOSE.
This spontaneous report was received from a Licensed Practical Nurse refers to an unknown number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored GARDASIL (lot#, expiry not reported). No adverse effects reported. The nurse stated that the vaccine was exposed to warmer temperatures. However, she had to research to determine if the vaccines were administered. This is 1 of several reports received from the same reporter. Additional information has been requested.
a larger red spot around the injection site; large red spot is itching; her arm became sore for a day; arm was itchy; arm was a little warm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 20-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm became sore for a day), PRURITUS (arm was itchy), FEELING HOT (arm was a little warm), VACCINATION SITE ERYTHEMA (a larger red spot around the injection site) and VACCINATION SITE PRURITUS (large red spot is itching) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (her arm became sore for a day), PRURITUS (arm was itchy) and FEELING HOT (arm was a little warm). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (a larger red spot around the injection site) and VACCINATION SITE PRURITUS (large red spot is itching). On 13-Jan-2021, PAIN IN EXTREMITY (her arm became sore for a day), PRURITUS (arm was itchy) and FEELING HOT (arm was a little warm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (a larger red spot around the injection site) and VACCINATION SITE PRURITUS (large red spot is itching) had not resolved.            Treatment information was not provided by reporter.   Action taken with the drug in response to the events was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Non significant follow up
-Severe Body soreness lasting one week -Extreme fatigue and muscle weakness lasting three weeks -Frequent muscle twitching lasting four and a half weeks (ongoing)
About 7:30 AM 9/3/03 the mother noticed swelling, redness and pain at the site of injection about 1-2 inches in size. Used cold packs and Tylenol. 9/4/03 The swelling had increased to include the entire upper arm. Notified her doctor. Arm was less red 9/5/03. 9/8/03 swelling subsided. No pain on head noted. Reaction did not cause her to miss any school.
After waking from nap, had a "beat red rash" on trunk and face and less pronounced on arms and legs.  On left side of face on cheek had approximately 12 "bumps".  No temperature but very irritable.
This spontaneous report as received from a medical assistant and refers to unspecified patients of unknown ages and genders. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. Since 26-JAN-2017, the patients were vaccinated with a dose of improperly stored VARIVAX which had a lot # of M025869 with expiration date of 24-MAY-2018 and M005972 with expiration date: 02-FEB-2018, however, dosage number and route of administration were not reported), for prophylaxis. Nevertheless, no adverse effects were reported. The vaccines experienced the following temperature excursions: on 26-JAN-2017 more than -15 degree centigrades (C), but less than 10 degree C (-12.7 degree C) during 1 hour and 4 minutes of; on 14-FEB-2017, more than -15 degree centigrades (C), but less than 10 degree C  (-11.1 degree C) for 6 hours and 4 minutes, and on 15-FEB-2017, more than -15 degree centigrades (C), but less than 8 degree C (-6.2 degree C) for 10 hours and 24 minutes. There had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. Additional information has been requested.; Sender's Comments: US-009507513-1702USA007294:
moderna covid-19 vaccine EUA. About 45 minutes after shot I got a slight headache. Early evening I got chills, worse headache and muscle aches. Saturday had a killer headache, severe muscle aches, extreme fatigue, dizzy and brain fog. The next day I had all of the same but less. Ate dinner night of the vaccine but did not eat or drink anything besides water again until 2 days later at 2pm as I had no appetite. When I ate my stomach hurt a little. I was tired for about 4 days and little appetite.
Red, inflamed, itchy rash around arm from shoulder down to elbow; Red, inflamed, itchy rash around arm from shoulder down to elbow; Red, inflamed, itchy rash around arm from shoulder down to elbow; her arm was very hot, her whole arm was red in that area and went around most of her arm; her arm was very hot, her whole arm was red in that area and went around most of her arm; This is a spontaneous report from a contactable consumer (patient). A 77-years-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6200), via an unspecified route on 28Feb2021 at 17:30 (at the age of 77-years) as dose 2, 0.3 ml single in the left arm for covid-19 immunisation. The patient medical history included Glaucoma from 2008, Lymphoma from 2012, Can break out in rash/contact dermatitis/eczema had skin issues her entire life. The patient concomitant medications included Pilocarpine Eye drops 4 %, 2x/day [4% one drop in right eye, twice a day], Dorzolamide 2 drop, 2x/day [one drop twice a day in both eyes], Latanoprost 2 drop, 1x/day [one drop in both eyes at bedtime] for glaucoma. Been taking these for several years, thinks she started in 2008 but doesn't remember exactly when. The patient previously received first dose of BNT162b2 (Lot Number: EL3248), via an unspecified route on 02Feb2021 (at the age of 77-years) as dose 1, single for covid-19 immunisation and experienced slightly tender at the site of injection. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Feb2021, the patient experienced red, inflamed, itchy rash around arm from shoulder down to elbow, her arm was very hot, her whole arm was red in that area and went around most of her arm. Patient was a consumer who received the second dose of the Covid-19 shot. Patient reports about five days later, she developed a rash around the injection site and went from her shoulder down to her elbow. Patient reports her arm was very hot, her whole arm was red in that area, and went around most of her arm. Patient clarified it was not a bumpy rash, just red, inflamed, and itchy. She had no side effects with the 1st dose, other than slightly tender at the site of injection, but she'd say basically no side effects. Benadryl and cream and it went away after about 5 days. Patient reports she can break out in a rash/contact dermatitis/eczema- but she hasn't had anything since 2013. It seems like the vaccine prompted the eczema/contact dermatitis to reappear, it was similar to what she's had before. Patient did not visited to emergency room/ physician office. The outcome of the events was recovered on 05Mar2021.  No follow-up attempts are Possible. No further information is expected.
Child started with a rash and  fever in the evening on 7/20/16.  The child was seen in the office on 7/21/16 for a fever, T101 degree F.(Temporal) and a red, papular rash on his whole body The baby came back on 7/22/16 with the rash worse, his hands and feet were swollen, and temperature was 99.2F. He was started on ZYRTEC 2.5ml as needed on 7/21/16.
At 2am that next morning January 8th (almost 12 hours post vaccine) I woke up out of my sleep delirious, light headed, heart was racing, diarrhea, and felt like I was falling in and out of almost passing out, hot flashes, couldn't think straight. It wasa very scary experience for me. This lasted about 15 or 20 minutes I'm guessing (hard to say for sure because I was too worked up to watch the clock) but I ended up making myself fall back asleep. The next day January 8th I had diarrhea multiple times in theafternoon and felt strange, somewhat lightheaded and some what felt like anxiety.
This is a 63y.o. female who presents to ER due to a fall at home.  She states that she was at home on her toilet when she became dizzy and fell forward, striking her head.  She takes Eliquis at home for atrial fibrillation.  She was also diagnosed with COVID-19 on January 2.  In the emergency department labs were consistent with urine tract infection.  CT imaging was negative for acute process, and she was started on Decadron for COVID-19 along with supplemental oxygen.   This morning the patient is complaining of her chronic low back pain and would like to have her home Norco restarted.  Blood cultures have been obtained and are pending.
pt recv 13JUN97 & 26JUN97 pt exp a fever of 100.5 & a pink target-like area 2 inches in diameter around the inj site;also devel a painful vesicular rash consisting of 3-5 lesions;
History of headaches x 1 yr. Worsening and persistent headaches onset 4/7/21 approximately 5 hrs. after Moderna vaccine dose #1. Associated symptoms include difficulty concentrating. Denies any changes after Moderna vaccine dose #2 on 5/5/21.
Strong headache and neck paon after two weeks of vaccination. Burning eyes. Leg pain. Difficulty to focus. Mind foggy.  Tested for antibodoes for covid and vaccone resulted negatives after one month of vacconation and then again after 3 monthz. However had high autoinmune response. Headache and neck pain continued. Had N mri and neurologiat evaliation but nothing founf. Headaxhe continued and leg pain and stiffness also. Now also continuous ringing in my ears abd hot ears. Veins in my arm are unusually darker abd more visiblw.
No Additional AE; HCP called and informed a patient received a pediatric dose of VAQTA.; HCP called and informed a patient received a pediatric dose of VAQTA.; This spontaneous report was received from a nurse and refers to a 73-year-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 04-APR-2023, the patient was vaccinated with pediatric dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (strength, lot #, expiry date, exact dose and route of administration were not provided) administered for prophylaxis (incorrect dose administered and product administered to patient of inappropriate age). No additional adverse event was reported.; Sender's Comments:  US-009507513-2305USA003050:
This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of VAQTA (lot#, frequency, and route of administration were unspecified) for prophylaxis, following a temperature excursion of 24 Fahrenheit degrees for 1 hour and 45 minutes which was found because of a digital data logger (there were no previous excursions). No adverse effects were reported.
Nausea, stomach cramps, dizzy, cold sweats, changing from hot to cold to hot and clammy hands.
(lt) arm - reddened, "hst to touch", swollen - taken to Urgent care by Mom - 4-1-09 - Placed on KEFLEX po tid - arm resolved 4-30-09
Freezing cold and uncontrollable whole body muscular contractions, chills, started at around 8:00PM on injection day, lasted about 2 hours Next morning , blood in nose at around 8:00AM.  Single event.
This spontaneous report as received from a physician's assistant refers to a patent of unknown age and gender. On 20-AUG-2015, the patient as vaccinated with an improperly stored dose of M-M-R II (lot # L003855 exp date 05-FEB-2017) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports from the same source. Additional information is not expected as all follow up information to complete the case was received.
pt recv vax;ran fever of 103-105; irritable;no local rxn of inject site;2 days later, had ear infect; ATBs given;
Fever to 102 developed about 3 hours after IZS Pediarix, Hib, PCV7, irritable, SX cont to 7/13/06 midday.
About 2 hours after receiving the vaccine, the patient returned to the pharmacy while shopping in the store because she believed to be having an adverse effect to the vaccine. She had a mildly swollen, itchy, red, bumpy patch about 3 inches in diameter on the entire back of her left hand. The rash was localized to the back of her hand and did not extend up her arm and was not present near the injection site. She denied contact with irritants throughout the store. The patient had no other reaction to the first dose other than a sore arm. To treat the reaction, the patient purchased and took a diphenhydramine 25 mg tablet.
Patient received Monovalent Moderna 0.5ml blue cap purple label.  Patient was intended to receive Bivalent Moderna 0.5ml blue cap gray label.
Irritation/itching, induration, erythema, heat at site. Mild dull headache.
After given the shot, was asked to sit in waiting area for 15 minutes to make sure no reactions. About 8-10 minutes my whole body felt hot, my head felt dizzy, faint-like, my mouth got dry and couldn't swallow. Had someone get the nurse for me, she asked if I was itchy and said no. Just felt like my throat was hot and burning and couldn't swallow. She had me take off my mask, take deep breaths, gave me a bottle water, could hardly swallow the water. She called 911 and nurse gave me an Epi Shot while waiting for paramedics. Paramedics came and evaluated me and said I had no rash and blood pressure was super high; but could have been due to EpiPen shot. Went home, took benadryl. Never got a rash or any other allergic symptoms, just extreme muscle pain in all of my body.
Bone pain; Tremors; difficulty breathing since her nose and throat seem stuffy; No appetite; no taste; Upper arm pain; nose and throat seem stuffy; fever; Body aches; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bone pain), TREMOR (Tremors), DYSPNOEA (difficulty breathing since her nose and throat seem stuffy), DECREASED APPETITE (No appetite) and AGEUSIA (no taste) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 011m20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (Lactose) and Colon cancer.   On 20-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced BONE PAIN (Bone pain), TREMOR (Tremors), DYSPNOEA (difficulty breathing since her nose and throat seem stuffy), DECREASED APPETITE (No appetite), AGEUSIA (no taste), PAIN IN EXTREMITY (Upper arm pain), NASAL CONGESTION (nose and throat seem stuffy), PYREXIA (fever), MYALGIA (Body aches), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, BONE PAIN (Bone pain), TREMOR (Tremors), DYSPNOEA (difficulty breathing since her nose and throat seem stuffy), DECREASED APPETITE (No appetite), AGEUSIA (no taste), NASAL CONGESTION (nose and throat seem stuffy), PYREXIA (fever), MYALGIA (Body aches), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown and PAIN IN EXTREMITY (Upper arm pain) had not resolved.            The patient did not take any concomitant medications. No treatment information was reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Reporter address, patient demographics, medical history, first dose date and lot number, additional event, medically confim.
Information has been received from a physician concerning a patient who was vaccinated PO with a dose of Rotateq. The physician reported that, about one week after being vaccinated, the patient developed severe diarrhea. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested. 08/31/07 This is in follow-up to report(s) previously submitted on 4/13/2007. No further information is available.
Blood sugar drop immediately after first dose; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for two patients. This is the second dose of two reports. A 31-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blood sugar drop immediately after first dose in Dec2020 with outcome of unknown. This report is considered as non-serious.   No follow-up attempts are possible. Information on lot/batch number could not be obtained.; Sender's Comments: Linked Report(s) :  same reporter/drug, similar event, different patients
Blistering; Itching; This case was reported by a consumer via call center representative and described the occurrence of blister in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th November 2021, the patient received the 1st dose of Shingrix. In November 2021, less than a week after receiving Shingrix, the patient experienced blister and pruritus. On an unknown date, the outcome of the blister and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the blister and pruritus to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. The age at vaccination was not reported. The patient received her first Shingrix vaccine and was now experiencing blistering and itching. This was not resolved.  The reporter did not consent to follow-up. No health care professional information provided. No demographics were obtained.
Information has been received from a consumer concerning her friend, a 72 year old female who in approximately June 2006 (about two years ago) was vaccinated with a dose of ZOSTAVAX vaccine (Oka/Merck). "Recently", the patient developed shingles. The patient's outcome was unknown. It was unspecified if any medical attention was sought. Additonal information has been requested.
Hives, itching and redness, skin develops hives after 5-10 minutes if rubbed or scratched, hives remain 1-2 hours before fading. Began taking Benadryl with little effect.
hives itchy and scratchy; Fever; On the arm of Injection two circles, red circles; Hives; Asthma cough; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Asthma cough), PRURITUS (hives itchy and scratchy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (On the arm of Injection two circles, red circles) and URTICARIA (Hives) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0121220A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Drug allergy (Aspirin and Tylenol).    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced COUGH (Asthma cough). On 10-Jan-2021, the patient experienced PRURITUS (hives itchy and scratchy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (On the arm of Injection two circles, red circles) and URTICARIA (Hives). At the time of the report, COUGH (Asthma cough), PRURITUS (hives itchy and scratchy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (On the arm of Injection two circles, red circles) and URTICARIA (Hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient had 2 vaccines administered on 11-28-11 MENACTRA and adult Td (DECAVAC).
Persistent hives and dermotographia, well managed with Zyrtec, but returns if Zyrtec is not taken within 24 hours
pt had MMR & HIB on 1JUN94; next day exp high fever & sz of 2 mins duration according to father; family did not have a thermometer; family called ambulance who took pt to ER; MD felt react was from a virus casuing the fever;